Moral distress and protective work environment for healthcare workers during public health emergencies

Autor: K. Bondjers, Alve K. Glad, H. Wøien, T. Wentzel-Larsen, D. Atar, SK. Reitan, LA. Rosseland, JA. Zwart, G. Dyb, SØ. Stensland

Publikováno v: BMC Medical Ethics, Vol 25, Iss 1, Pp 1-9 (2024)

Abstract Background Public health emergencies, such as the Covid-19 pandemic, put great pressure on healthcare workers (HCW) across the world, possibly increasing the risk of experiencing ethically challenging situations (ECS). Whereas experiencing E

Externí odkaz: https://doaj.org/article/2eb6a09e5752483aab1c092cb276b4b7

Remission in schizophrenia spectrum disorders: A randomized trial of amisulpride, aripiprazole and olanzapine.

Autor: Drosos P; NORMENT, Division of Psychiatry, Haukeland University Hospital, Bergen 5036, Norway; Department of Clinical Medicine, University of Bergen, Bergen 5007, Norway; TIPS-Network for Clinical Research in Psychosis, Clinic For Adult Mental Health, Stavanger University Hospital, Stavanger 4011, Norway. Electronic address: drpe@sus.no., Johnsen E; NORMENT, Division of Psychiatry, Haukeland University Hospital, Bergen 5036, Norway; Department of Clinical Medicine, University of Bergen, Bergen 5007, Norway., Bartz-Johannessen CA; NORMENT, Division of Psychiatry, Haukeland University Hospital, Bergen 5036, Norway., Larsen TK; Department of Clinical Medicine, University of Bergen, Bergen 5007, Norway; TIPS-Network for Clinical Research in Psychosis, Clinic For Adult Mental Health, Stavanger University Hospital, Stavanger 4011, Norway., Reitan SK; Institute for Mental Health, St Olav's University Hospital, Trondheim 7030, Norway; Department of Mental Health, Norwegian University of Natural Science and Technology, Trondheim 7491, Norway., Rettenbacher M; Department of Psychiatry and Psychotherapy, Medical University Innsbruck, Innsbruck 6020, Austria., Kroken RA; NORMENT, Division of Psychiatry, Haukeland University Hospital, Bergen 5036, Norway; Department of Clinical Medicine, University of Bergen, Bergen 5007, Norway.

Publikováno v: Schizophrenia research [Schizophr Res] 2024 Sep; Vol. 271, pp. 9-18. Date of Electronic Publication: 2024 Jul 14.

Autor: Kvestad CA, Reitan SK

Publikováno v: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke [Tidsskr Nor Laegeforen] 2024 Aug 27; Vol. 144 (10). Date of Electronic Publication: 2024 Aug 27 (Print Publication: 2024).

Transdiagnostic Associations between Anger Hostility and Chemokine Interferon-gamma Inducible Protein 10.

Autor: Soloey-Nilsen H; Department of Mental Health and Addiction Medicine, Nordland Hospital Trust, Bodoe, Norway.; Institute of Clinical Medicine, UIT The Arctic University of Norway, Tromsoe, Norway., Nygaard-Odeh K; Department of Mental Health and Addiction Medicine, Nordland Hospital Trust, Bodoe, Norway.; Institute of Clinical Medicine, UIT The Arctic University of Norway, Tromsoe, Norway., Kristiansen MG; Department of Mental Health and Addiction Medicine, Nordland Hospital Trust, Bodoe, Norway.; Institute of Clinical Medicine, UIT The Arctic University of Norway, Tromsoe, Norway., Kvig EI; Department of Mental Health and Addiction Medicine, Nordland Hospital Trust, Bodoe, Norway.; Institute of Clinical Medicine, UIT The Arctic University of Norway, Tromsoe, Norway., Brekke OL; Department of Mental Health and Addiction Medicine, Nordland Hospital Trust, Bodoe, Norway.; Institute of Clinical Medicine, UIT The Arctic University of Norway, Tromsoe, Norway., Mollnes TE; Department of Mental Health and Addiction Medicine, Nordland Hospital Trust, Bodoe, Norway.; Department of Laboratory Medicine, Research Laboratory, Nordland Hospital Trust, Bodoe, Norway.; Department of Immunology, Oslo University Hospital, University of Oslo, Oslo, Norway.; Centre of Molecular Inflammation Research, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Berk M; Barwon Health, The Institute for Mental and Physical Health and Clinical Translation (IMPACT), School of Medicine, Deakin University, Geelong, Australia.; Orygen, The National Centre of Excellence in Youth Mental Health, Centre for Youth Mental Health, Florey Institute for Neuroscience and Mental Health and the Department of Psychiatry, The University of Melbourne, Melbourne, Australia., Reitan SK; Department of Mental Health (IPH), Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.; Nidelv Community Center of Mental Health, St. Olavs Hospital, Trondheim, Norway., Oiesvold T; Department of Mental Health and Addiction Medicine, Nordland Hospital Trust, Bodoe, Norway.; Institute of Clinical Medicine, UIT The Arctic University of Norway, Tromsoe, Norway.

Publikováno v: Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology [Clin Psychopharmacol Neurosci] 2024 May 31; Vol. 22 (2), pp. 285-294. Date of Electronic Publication: 2023 Jul 17.

Cellular adhesion molecules in drug-naïve and previously medicated patients with schizophrenia-spectrum disorders.

Autor: Varden Gjerde K; NKS Olaviken Gerontopsychiatric Hospital, Erdal, Norway; Department of Clinical Medicine (K1), University of Bergen, Bergen, Norway; NORMENT Centre of Excellence, Division of Psychiatry, Haukeland University Hospital, Bergen, Norway. Electronic address: kristian.varden.gjerde@olaviken.no., Bartz-Johannessen C; NORMENT Centre of Excellence, Division of Psychiatry, Haukeland University Hospital, Bergen, Norway., Steen VM; NORMENT Centre of Excellence, Department of Clinical Science (K2), University of Bergen, Bergen, Norway; Dr. Einar Martens Research Group for Biological Psychiatry, Department of Medical Genetics, Haukeland University Hospital, Bergen, Norway., Andreassen OA; NORMENT Centre of Excellence, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Steen NE; NORMENT Centre of Excellence, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Ueland T; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway; Department of Clinical Medicine, Thrombosis Research Center, UiT - The Arctic University of Norway, Tromsø, Norway; Research Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway., Lekva T; Research Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway., Rettenbacher M; Medical University of Innsbruck; Department of Psychiatry, Psychotherapy and Psychosomatics, Innsbruck, Austria., Joa I; TIPS Center for Clinical Research in Psychosis, Division of Psychiatry, Stavanger University Hospital, Stavanger, Norway; Department of Public Health, Faculty of Health Science, University of Stavanger, Stavanger, Norway., Reitan SK; St. Olav University Hospital, Nidelv community mental health centre, Trondheim, Norway; Norwegian University of Science and Technology, Department of Mental Health, Trondheim, Norway., Johnsen E; Department of Clinical Medicine (K1), University of Bergen, Bergen, Norway; NORMENT Centre of Excellence, Division of Psychiatry, Haukeland University Hospital, Bergen, Norway., Kroken RA; Department of Clinical Medicine (K1), University of Bergen, Bergen, Norway; NORMENT Centre of Excellence, Division of Psychiatry, Haukeland University Hospital, Bergen, Norway.

Publikováno v: Schizophrenia research [Schizophr Res] 2024 May; Vol. 267, pp. 223-229. Date of Electronic Publication: 2024 Apr 03.